CAL-02
N/A
Report date: 2025/10/10 20:01:49
NME
Base Information
Drug NameCAL-02
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[19]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLascco Sa
China Registration ClassN/A
Develop Information
Active CompaniesEagle Pharmaceuticals Inc
Inactive CompaniesCombioxin Sa
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A